Your browser doesn't support javascript.
loading
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome.
Irie, Masahiro; Niihori, Tetsuya; Nakano, Tomohiro; Suzuki, Tasuku; Katayama, Saori; Moriya, Kunihiko; Niizuma, Hidetaka; Suzuki, Nobu; Saito-Nanjo, Yuka; Onuma, Masaei; Rikiishi, Takeshi; Sato, Atsushi; Hangai, Mayumi; Hiwatari, Mitsuteru; Ikeda, Junji; Tanoshima, Reo; Shiba, Norio; Yuza, Yuki; Yamamoto, Nobuyuki; Hashii, Yoshiko; Kato, Motohiro; Takita, Junko; Maeda, Miho; Aoki, Yoko; Imaizumi, Masue; Sasahara, Yoji.
Afiliación
  • Irie M; Department of Pediatrics, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Niihori T; Department of Medical Genetics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Nakano T; Department of Pediatrics, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Suzuki T; Department of Pediatrics, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Katayama S; Department of Pediatrics, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Moriya K; Department of Pediatrics, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Niizuma H; Department of Pediatrics, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Suzuki N; Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
  • Saito-Nanjo Y; Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
  • Onuma M; Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
  • Rikiishi T; Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
  • Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan.
  • Hangai M; Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  • Hiwatari M; Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  • Ikeda J; Department of Pediatrics, School of Medicine, Teikyo University, Tokyo, Japan.
  • Tanoshima R; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Shiba N; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Yuza Y; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
  • Yamamoto N; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Hashii Y; Department of Pediatrics, Kobe University Graduate School of Medicine, Hyogo, Japan.
  • Kato M; Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Takita J; Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan.
  • Maeda M; Department of Pediatrics, The University of Tokyo, Tokyo, Japan.
  • Aoki Y; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Imaizumi M; Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Sasahara Y; Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
Int J Hematol ; 117(4): 598-606, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36515795
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón